AZD0530 Difumarate clinical trials

Saracatinib Trial TO Prevent FOP

This study is testing a new drug called Saracatinib (also known as AZD0530) for people with Fibrodysplasia Ossificans Progressiva (FOP). It aims to see if the drug can prevent new bone from growing in soft tissues, which is a key problem in FOP.